Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,582 | 999 | 96.1% |
| Education | $597.48 | 13 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,787 | 153 | $0 (2024) |
| Novo Nordisk Inc | $1,777 | 127 | $0 (2024) |
| Astellas Pharma US Inc | $1,763 | 72 | $0 (2024) |
| PFIZER INC. | $1,114 | 78 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $939.48 | 67 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $848.73 | 71 | $0 (2024) |
| Amgen Inc. | $803.68 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $721.51 | 49 | $0 (2024) |
| Amarin Pharma Inc. | $672.17 | 36 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $660.98 | 56 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,398 | 86 | Lilly USA, LLC ($240.88) |
| 2023 | $1,835 | 117 | Astellas Pharma US Inc ($263.96) |
| 2022 | $2,098 | 120 | Lilly USA, LLC ($347.58) |
| 2021 | $2,071 | 137 | Astellas Pharma US Inc ($244.74) |
| 2020 | $1,696 | 101 | Astellas Pharma US Inc ($247.22) |
| 2019 | $1,545 | 105 | Janssen Pharmaceuticals, Inc ($247.41) |
| 2018 | $2,227 | 160 | Astellas Pharma US Inc ($389.13) |
| 2017 | $2,310 | 186 | Novo Nordisk Inc ($406.69) |
All Payment Transactions
1,012 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $11.14 | General |
| 09/30/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $12.96 | General |
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: VACCINES | ||||||
| 09/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: VACCINES | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: VACCINES | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.12 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,806 | 5,195 | $402,752 | $234,924 |
| 2022 | 25 | 3,252 | 5,977 | $451,219 | $266,513 |
| 2021 | 26 | 3,764 | 6,893 | $498,345 | $303,693 |
| 2020 | 27 | 4,264 | 7,770 | $460,738 | $281,125 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 535 | 1,541 | $161,805 | $84,514 | 52.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 378 | 378 | $51,030 | $45,821 | 89.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 373 | $57,815 | $27,921 | 48.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 188 | 188 | $16,920 | $13,519 | 79.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 163 | 163 | $17,930 | $12,119 | 67.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 49 | 57 | $15,675 | $11,722 | 74.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 177 | 230 | $14,950 | $8,045 | 53.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 233 | 791 | $19,995 | $6,812 | 34.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $6,900 | $6,487 | 94.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 192 | 192 | $5,760 | $5,472 | 95.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 31 | 33 | $6,930 | $5,021 | 72.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 55 | 70 | $5,600 | $2,631 | 47.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 32 | 49 | $2,695 | $1,407 | 52.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,475 | $1,167 | 47.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $600.00 | $588.00 | 98.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 15 | 15 | $865.00 | $388.36 | 44.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $400.00 | $340.80 | 85.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $400.00 | $340.80 | 85.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 70 | 258 | $3,096 | $249.59 | 8.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 100 | 365 | $5,475 | $130.75 | 2.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $825.00 | $125.41 | 15.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 29 | 36 | $288.00 | $79.20 | 27.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 170 | 274 | $3,288 | $21.85 | 0.7% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 11 | 69 | $1,035 | $1.09 | 0.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 582 | 1,701 | $178,605 | $95,465 | 53.5% |
About Dr. John Wessner, M.D
Dr. John Wessner, M.D is a Internal Medicine healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497723423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wessner, M.D has received a total of $15,180 in payments from pharmaceutical and medical device companies, with $1,398 received in 2024. These payments were reported across 1,012 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,582).
As a Medicare-enrolled provider, Wessner has provided services to 14,086 Medicare beneficiaries, totaling 25,835 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dothan, AL
- Active Since 03/08/2006
- Last Updated 08/26/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497723423
Products in Payments
- ELIQUIS (Drug) $1,205
- Ozempic (Drug) $942.33
- TRULICITY (Drug) $803.54
- Vascepa (Drug) $672.17
- JARDIANCE (Drug) $648.44
- MYRBETRIQ (Drug) $645.87
- ENTRESTO (Drug) $557.50
- XARELTO (Drug) $554.02
- FARXIGA (Drug) $531.19
- MOUNJARO (Drug) $474.17
- TRELEGY ELLIPTA (Drug) $472.07
- Kerendia (Drug) $438.99
- Myrbetriq (Drug) $312.34
- XIFAXAN (Drug) $307.24
- INVOKANA (Drug) $281.86
- Victoza (Drug) $252.56
- UBRELVY (Drug) $246.72
- Tresiba (Drug) $243.12
- BELSOMRA (Drug) $230.58
- EVENITY (Biological) $211.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dothan
Justin Hovey, M.d, M.D
Internal Medicine — Payments: $40,901
Dr. Sebastian Heersink, Md, MD
Internal Medicine — Payments: $33,960
Dr. Christopher Miller, M.d, M.D
Internal Medicine — Payments: $16,529
Dr. James Conner, M.d, M.D
Internal Medicine — Payments: $14,834
Frank Crockett, M.d, M.D
Internal Medicine — Payments: $14,445
Dr. Anthony Spedale, Md, MD
Internal Medicine — Payments: $14,067